Skip to content
Sign in

ACIU · NASDAQ

AC Immune SA (ACIU) Stock Price & Fundamentals

$627.75−1.05%−$6.64End-of-day price as of Oct 9, 2026

AC Immune SA (ACIU) closed at $627.75 on Oct 9, 2026, down 1.05% from the previous close of $634.39.

Share price, past year

1Y −5.05%
Daily closing prices

52-week range $612.57 – $695.00.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$627.75
Sep 30, 2026$631.24
Aug 31, 2026$637.01
Jul 31, 2026$648.44
Jun 30, 2026$614.02
May 29, 2026$637.30
Apr 30, 2026$642.72
Mar 31, 2026$637.33
Feb 27, 2026$643.31
Jan 30, 2026$669.64
Dec 31, 2025$656.56
Nov 28, 2025$645.93
Oct 31, 2025$642.86

Key statistics

Market cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Net income (TTM)
—
Shares outstanding
101.7M
Dividend yield
—
52-week range
$612.57 – $695.00

Market cap, P/E and dividend yield aren't shown for AC Immune SA yet: its SEC filings count its ordinary shares, which can differ from the shares traded in the US, and report in Swiss francs.

Financials

AC Immune SA reported revenue of CHF 3.57M for fiscal 2025, down 86.92% from fiscal 2024.

Figures are in Swiss francs (CHF), as AC Immune SA reports them to the SEC.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
AC Immune SA annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025CHF 3.57M−86.9%——−CHF 0.70−CHF 70.16M
FY2024ended Dec 31, 2024CHF 27.31M+84.5%——−CHF 0.51CHF 65.27M
FY2023ended Dec 31, 2023CHF 14.80M+276.1%——−CHF 0.64−CHF 61.21M
FY2022ended Dec 31, 2022CHF 3.94M———−CHF 0.85−CHF 74.81M
FY2021ended Dec 31, 2021CHF 0.00−100.0%——−CHF 0.97−CHF 68.32M
FY2020ended Dec 31, 2020CHF 15.43M−86.0%——−CHF 0.86−CHF 61.22M
FY2019ended Dec 31, 2019CHF 110.46M+1,498.0%——CHF 0.64CHF 53.34M
FY2018ended Dec 31, 2018CHF 6.91M−65.9%——−CHF 0.82−CHF 45.94M
FY2017ended Dec 31, 2017CHF 20.26M−12.8%——−CHF 0.46−CHF 23.90M
FY2016ended Dec 31, 2016CHF 23.21M———−CHF 0.14−CHF 6.55M
AC Immune SA quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2025ended Jun 30, 2025CHF 1.31M—−CHF 0.21
Q2 FY2024ended Jun 30, 2024CHF 687.00K—−CHF 0.23
Q2 FY2023ended Jun 30, 2023CHF 0.00—−CHF 0.20
Q3 FY2022ended Sep 30, 2022CHF 3.93M—−CHF 0.16
Q2 FY2022ended Jun 30, 2022CHF 0.00—−CHF 0.23
Q3 FY2021ended Sep 30, 2021CHF 0.00—−CHF 0.22
Q4 FY2017ended Dec 31, 2017CHF 16.42M—CHF 0.07
Q3 FY2017ended Sep 30, 2017CHF 1.07M—−CHF 0.15

Company profile

Name
AC Immune SA
Ticker
ACIU
Exchange
NASDAQ
Industry (SEC SIC)
Pharmaceutical Preparations
Headquarters
Epfl Innovation Park, Building B, 1015 Lausanne, V8 00000
Incorporated in
V8
Fiscal year ends
December
SEC CIK
0001651625

Recent SEC filings

Frequently asked questions

What is AC Immune SA's stock price?

AC Immune SA (ACIU) closed at $627.75 on Oct 9, 2026, down 1.05% from the previous close of $634.39.

How much revenue does AC Immune SA make?

AC Immune SA reported revenue of CHF 3.57M for fiscal 2025, down 86.92% from fiscal 2024.

Sources and methodology

Fundamentals come from AC Immune SA's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures